Novel Immunotherapeutic Strategies
- Adoption of CAR-T cell therapy in cancer treatment
- Innovations in monoclonal antibody design
- Exploring vaccine adjuvants for enhanced efficacy
International Conference on Immunology and Advanced Therapeutic Research
Call for Papers – ICIATR 2027, Charlotte
Charlotte, USA
Conference home
Science Guru invites academicians, researchers, engineers, industry participants and students to submit original research papers to the International Conference on Immunology and Advanced Therapeutic Research (ICIATR-2027), held in Charlotte, USA on 19 March 2027.
Research tracks
Call for papers ICIATR 2027
Original research papers, abstracts, case studies and review papers are welcome. Topics include, but are not limited to:
Immunological Mechanisms in Disease
- Role of immune checkpoints in autoimmune diseases
- Understanding innate immunity in infectious diseases
- Mechanisms of immune tolerance and their therapeutic implications
Translational Research in Immunology
- Bridging laboratory research to clinical applications
- Impact of biomarker discovery on therapeutic outcomes
- Use of patient-derived models for immunotherapy research
Challenges in Immunological Research
- Ethical considerations in human immunology studies
- Overcoming barriers in cross-disciplinary collaboration
- Navigating regulatory frameworks for therapeutic innovations
Emerging Technologies in Immunology
- Applications of CRISPR in immunological research
- Utilizing AI for immunotherapy discovery
- Advances in bioinformatics for immune profiling
Timeline
Important dates of ICIATR 2027
-
Paper submission deadline
-
Early bird registration ends
-
Last date of registration
-
Date of conference
Registrations after the last date of registration may not be accepted. Questions? Email [email protected].
Contact
Contact the ICIATR 2027 team
Questions about submission, registration, the invitation letter or publication? Send us a message and the conference team will reply by email.
- Email[email protected]
- Conference locationCharlotte, USA, 19 March 2027